BT424900

Pioneering a personalized approach to skincare, leveraging breakthroughs in genetics and AI to develop truly customized anti-aging solutions. Unlike typical skincare products that offer superficial benefits, this company targets the root causes of skin aging—genetic and epigenetic factors—through a patent-pending skin age testing kit and a precision-formulated anti-aging cream.

Backed by leading scientists from Harvard and the University of Toronto, they are on track to expand their innovative approach into broader disease categories like Alzheimer's and cancer. Positioned in a $273 billion global market, they aim to disrupt the industry and deliver scientifically validated, personalized skincare solutions that not only slow aging but redefine beauty itself. Their solution addresses unmet needs with cutting-edge technology and a clear path for rapid market penetration, making this a transformative opportunity for investors seeking to tap into the future of skincare and biotech.

Overview

Industry: Personalized Skincare, Anti-Aging Solution
Founded: 2024
Mission: To revolutionize skincare by leveraging AI and genetic research to provide personalized treatment plans and products that target the root causes of skin aging.
Vision: To lead the market in personalized, science-backed skincare solutions, eventually expanding into broader anti-aging treatments for diseases such as Alzheimer’s, osteoporosis, and cancer.
Unique Value Proposition: Offers a personalized skincare solution based on genetic data and AI-generated treatment plans, aiming to address the underlying genetics of aging rather than just the symptoms.

Problem & Solution

Problem: There are 1.88 billion people worldwide are over the age of 50+, and the market lacks effective products that genuinely reverse skin aging and provide significant benefits. Additionally, there is no widely available personalized skin testing and treatment plan that informs customers about their skin condition and age.
Solution: The company offers two innovative products: a personalized skin age testing kit (already filed for IP protection) that uses 57 scientific parameters to assess skin quality and age, and a skin anti-aging cream formulated with small molecules targeting genetic causes of aging. These solutions are designed to provide personalized, effective skincare based on individual genetic data, targeting the root of cause of aging.

Market Potential

Target Market: Global Skincare Market
Market Size: Estimated at $273 billion by 2031, with a CAGR of 6.7%.
Total Addressable Market (TAM): The TAM for the global skincare market includes all skincare products sold worldwide. According to various market research reports, the global skincare market was valued at approximately $130-$150 billion in 2023 and is expected to continue growing due to factors like increasing consumer awareness, rising disposable incomes, and demand for personalized solutions.
Serviceable Available Market (SAM): $15 billion for the premium skincare segment globally.
Serviceable Obtainable Market (SOM): Potential growth starting at a small percentage of the SAM, with room to expand through increased brand recognition and effective marketing.
Growth Rate: The market is expected to continue growing at a similar or slightly higher CAGR, ranging between 5% and 7% from 2023 to 2030. This growth is fueled by trends such as the increasing focus on anti-aging products, the rise of skincare routines in younger consumers, and the expansion of e-commerce.
Trends: Growing demand for anti-aging products, biotech cosmetics, and personalized skincare solutions; increased online shopping preferences.
Customer Segments: Growing demand for anti-aging products, biotech cosmetics, and personalized skincare solutions; increased online shopping preferences.

Patients looking for effective solutions
Biopharmaceutical companies based in the USA and Europe
Cosmetic companies operating in the USA and Europe
Dermatologists
Retail Consumers / Individuals

Product / Service

Core Features: Personalized skin testing and AI-generated treatment plans; products targeting genetic and epigenetic factors of skin aging.
Technology Stack: Involves advanced AI for drug screening and prediction, bioinformatics, and small molecule synthesis.
Development Stage: Currently at the prototype stage, with a product roadmap to refine AI personalization and develop anti-aging formulations within 6-12 months.
Intellectual Property: Patent filed for personalized skin testing kit.
Product Roadmap:

Upcoming Features: AI-generated personalized treatment plan; small molecule cocktail targeting specific customer needs.
‍
Development Timeline: 6-12 months to complete AI-generated personalization and small molecule for anti-aging cream.

Business Model

Revenue Model: Product sales through an online store and retail partnerships, subscription services for regular shipments at discounted rates.
Sales Channels: E-commerce platform, premium department stores, health-focused retailers, and subscription services.
Customer Acquisition Strategy: Digital marketing (social media, email, SEO), influencer partnerships, and targeted content creation.
Key Potential Partnerships: Influencers and Beauty Bloggers (Micro-Influencers, Beauty and Skincare Experts), Retail Partnerships (Health and Beauty Stores, Online Marketplaces), Wellness and Lifestyle Brands (Yoga and Fitness Studios, Subscription Boxes), Environmental and Ethical Organizations (Sustainable Packaging Companies, Environmental Nonprofits), Hospitality Industry (Luxury Hotels and Spas, Wellness Retreats), Fashion and Beauty Brands (Ethical Fashion Brands, Makeup Brands), Influencer-Led Skincare Lines (Collaboration with Influencers on Product Development), Corporate Partnerships (Employee Wellness Programs, Corporate Gifting)

Financials

Current Status: Pre-revenue with a burn rate of $1,000 per month and a runway of 20 months.
Funding to Date: $20,000.
Use of Funds: Team formation, legal, patent, R&D, fundraising
Financial Projections: Revenue targets are $500,000 in 2025, $1 million in 2026, $2 million in 2027, and $5 million in 2028. Projected net profit margins grow from 15% in 2025 to 60% in 2028.
Key Financial Metrics (projected numbers):

Customer Acquisition Cost (CAC): $50 per customer.
Lifetime Value (LTV): $1,200 per customer.
Gross Margin: 60%.
Net Profit Margin: 15%

Team

Founder: PhD from the University of Toronto, Postdoc fellow at Harvard Medical School.
Roles and Responsibilities: Research and development, raising capital, forming teams.
Key Team Members:

CTO: PhD from Harvard Medical School, focuses on technological development.
Machine Learning Engineer: responsible for AI and machine learning integration.
Hiring Plans:
‍
Current Team Size: 4
Future Hiring Plans: 2 extra team members within 12 months

Competitive Analysis

Competitive Advantage: Superior analytical capabilities using genetic and epigenetic parameters, more comprehensive and personalized testing, and product offerings that are science-backed and competitively priced.
Competition: Direct competitors include companies offering skin sampling and testing kits. (Email us for detailed information).

Risks & Mitigation

Market Risks: Highly competitive landscape, changing consumer preferences, economic downturns.
Operational Risks: Supply chain disruptions, quality control issues, scalability challenges.
Financial Risks: High customer acquisition costs, cash flow management challenges, and reliance on external funding.
Regulatory Risks: Compliance with cosmetic and environmental regulations, and global trade policies.
Mitigation Strategies: Diversification of product offerings, strong supplier relationships, investment in quality control, focus on customer retention, maintaining healthy cash flow, ensuring regulatory compliance, and fostering a culture of adaptability.

Funding Requirements

Amount Being Raised: $2.5 million
Use of Funds: Allocated towards lab equipment, AI drug screening, chemical synthesis, marketing, manufacturing, team salaries, legal expenses, and insurance.
Expected Runway: 24 months with new funding.

Exit Strategy

Potential Scenarios:

Acquisition by a larger company.
Initial Public Offering (IPO).
Merger with another brand.
Management buyout.
Strategic partnerships or licensing.
Selling to private equity.
Considerations: The choice of exit strategy will depend on market conditions, brand performance, and strategic opportunities.